• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

News of the day

PR Newswire search

Most viewed

KORRES Q1 2008 Results

Torchmark Corporation Reports First Quarter 2008 Results

Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results

Essilor - First-Half 2008 Revenue

Shire plc: IFRS Results for the Year Ending December 31, 2007

More recent news

Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
11th November 2008 SAN DIEGO, November 11 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced financial results for the third quarter and nine months ended September 30, 2008, and...

The Binding Site Announces Trading Update for Year Ended September 30th 2008
11th November 2008 BIRMINGHAM, England, November 11 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately-owned specialist UK diagnostics company, today announces a trading update...

Hoya Announces Second Quarter and First Half Financial Results for FY2008
10th November 2008 TOKYO, November 10 /PRNewswire/ -- HOYA Corporation today announced financial results for the second quarter ended September 30, 2008. Net sales were 128.3 billion yen for the quarter, representing...

Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2008
4th November 2008 KVISTGARD, Denmark, November 4 /PRNewswire/ -- In the first nine months of 2008 Bavarian Nordic generated revenue of DKK 45 million and recorded a loss before tax of DKK 195 million. The expectations...

Genmab Announces Results for the First Nine Months of 2008
29th October 2008 COPENHAGEN, Denmark, October 29 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2008. During this period, Genmab reported the following...

Genmab Announces Results for the First Nine Months of 2008
29th October 2008 COPENHAGEN, Denmark, October 29 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2008. During this period, Genmab reported the...

Shire's New Product Portfolio Delivers Strong Quarterly Performance
29th October 2008 PHILADELPHIA, Pennysylvania and DUBLIN, Ireland, October 29 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months...

Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
27th October 2008 ANTONY, France, October 27 /PRNewswire/ -- Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R)...

Sun Pharma Continues Strong Performance
25th October 2008 MUMBAI, India, October 25 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) reported strong growth for the second quarter ending Sep...

Essilor - Financial Information for the First Nine Months of 2008
23rd October 2008 CHARENTON-LE-PONT, France, October 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,...

Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
15th October 2008 ANTONY, France, October 15 /PRNewswire/ --

Gerresheimer Substantially Increases Quarterly Operating Profit
15th October 2008 D

ThromboGenics Announces Half Year Results 2008
28th August 2008 LEUVEN, Belgium, August 28 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today...

Essilor's First-Half 2008 Results
28th August 2008 CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six months...

Genmab Announces 2008 First Half Year Results
27th August 2008 COPENHAGEN, August 27 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the six month period ended June 30, 2008. During this period, Genmab reported the following results: ...

Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
27th August 2008 ANTONY, France, August 27 /PRNewswire/ -- The Board of Directors, meeting today under the chairmanship of Albert Saporta, approved STALLERGENES' half year consolidated financial statements:

Rosetta Genomics Reports Second Quarter 2008 Financial Results
19th August 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products, reported today...

Senetek PLC Reports Second Quarter 2008 Financial Results
14th August 2008 NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Amsterdam Molecular Therapeutics Reports Half Year Results 2008
13th August 2008 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008.

Amsterdam Molecular Therapeutics Reports Half Year Results 2008
13th August 2008 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008.

Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
12th August 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, August 12 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on August 19, 2008, before the...

Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
12th August 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, August 12 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on August 19, 2008, before the...

Nventa Biopharmaceuticals Corporation Announces Second Quarter 2008 Financial Results and Recent Corporate Highlights
12th August 2008 SAN DIEGO, August 12 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the second quarter and six months ended June 30, 2008, and highlighted...

Nventa Biopharmaceuticals Corporation Announces Second Quarter 2008 Financial Results and Recent Corporate Highlights
12th August 2008 SAN DIEGO, August 12 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the second quarter and six months ended June 30, 2008, and highlighted...

AMT to Release Half Year 2008 Results on August 13, 2008
5th August 2008 AMSTERDAM, The Netherlands, August 5 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial...

Misys Announces Preliminary Results for the Year Ended 31 May 2008
24th July 2008 LONDON, July 24 /PRNewswire/ -- Key Highlights Misys plc (FTSE: MSY.L) delivers results ahead of expectations and is now raising targets for the next phase of the turnaround. Misys generated...

GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
23rd July 2008 LONDON, July 23 /PRNewswire/ -- In a video interview, new CEO Andrew Witty comments on GSK's second quarter results while also updating the market on his strategic vision for the business. The...

Essilor - First-Half 2008 Revenue
17th July 2008 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR1,520.3 million for the six months...

Gerresheimer Further Increases its Sales and Earnings Power
15th July 2008 DÃœSSELDORF, Germany, July 15 /PRNewswire/ --

Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
10th July 2008 ANTONY, France, July 10 /PRNewswire/ --

Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
4th July 2008 BASINGSTOKE, England and PHILADELPHIA, July 4 /PRNewswire/ -- Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on...

The Binding Site: Financial Results for the Six Months Ended 31st March 2008
30th June 2008 BIRMINGHAM, England, June 30 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately owned specialist UK diagnostics company, today announces its results for the...

Rosetta Genomics Reports First Quarter 2008 Financial Results
21st May 2008 REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, May 21 /PRNewswire/ --

Senetek PLC Reports First Quarter 2008 Financial Results
15th May 2008 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
15th May 2008 PRINCETON, New Jersey, May 15 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to...

Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
14th May 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008, before the...

KORRES Q1 2008 Results
13th May 2008 ATHENS, May 13 /PRNewswire/ --

Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
9th May 2008 ST. DAVID'S, Bermuda, May 9 /PRNewswire/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31,...

Hoya Announces Fourth Quarter and FY2007 Financial Results
28th April 2008 TOKYO, Japan, April 28 /PRNewswire/ -- HOYA Corporation today announced fourth quarter net sales of 135.8 billion yen for the period ended March 31, 2008, a 36.5% increase over the same quarter of...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
25th April 2008 BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March...

Essilor's 2008 First-Quarter Report
23rd April 2008 CHARENTON-LE-PONT, France, April 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR762.2 million for the three months ended...

Torchmark Corporation Reports First Quarter 2008 Results
16th April 2008 MCKINNEY, Texas, April 16 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2008, net income was US$1.29 per share compared with US$1.37 per share...

STALLERGENES: 2008 1st Quarter Sales up 15%
15th April 2008 PARIS, April 15 /PRNewswire/ --